Microfragmented Adipose Tissue Injection (MFAT) May Be a Solution to the Rationing of Total Knee Replacement: A Prospective, Gender-Bias Mitigated, Reproducible Analysis at Two Years

Table 7

Patients grouped by KL OA grade at time of treatment (baseline) with follow-up OKS at 3, 6, 12, and 24 months.

Gender	OKS period	Count	Mean	Median	SD	Data
Female	0	104	25.7	25.5	7.5	d1
Female	1	104	32.2	32.0	9.3	d1
Female	2	104	32.2	33.5	9.3	d1
Female	3	104	34.0	34.0	9.1	d1
Female	4	104	36.7	38.0	7.1	d1
Male	0	127	29.5	29.0	8.4	d1
Male	1	127	34.7	37.0	8.5	d1
Male	2	127	33.7	33.0	8.2	d1
Male	3	127	34.5	37.0	10.1	d1
Male	4	127	32.5	34.0	10.6	d1
Female	0	46	26.3	24.5	10.5	d2
Female	1	46	31.5	34.0	10.3	d2
Female	2	46	31.0	35.0	13.0	d2
Female	3	46	37.1	40.0	9.7	d2
Female	4	46	32.5	36.0	12.3	d2
Male	0	67	31.3	33.0	10.6	d2
Male	1	67	35.6	38.0	8.8	d2
Male	2	67	36.1	38.5	9.6	d2
Male	3	67	37.7	37.0	6.8	d2
Male	4	67	40.9	42.0	4.6	d2

OKS period: 0—baseline, 1—3 months postinjection, 2—6 months postinjection, 3—12 months postinjection, 4—24 months postinjection. Count: the number of patients in each group. Mean, median, and SD (standard deviation). Data: d1—KL OA grade 4 at the time of treatment, d2—KL OA grade 3 at the time of treatment.